JP2006522062A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006522062A5 JP2006522062A5 JP2006504970A JP2006504970A JP2006522062A5 JP 2006522062 A5 JP2006522062 A5 JP 2006522062A5 JP 2006504970 A JP2006504970 A JP 2006504970A JP 2006504970 A JP2006504970 A JP 2006504970A JP 2006522062 A5 JP2006522062 A5 JP 2006522062A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- dihydro
- benzodiazepine
- dioxolo
- aminophenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0307860.7A GB0307860D0 (en) | 2003-04-04 | 2003-04-04 | Organic compounds |
| PCT/EP2004/003518 WO2004087161A1 (en) | 2003-04-04 | 2004-04-02 | Combinations comprising anti-epileptic drugs for the treatment of neurological disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006522062A JP2006522062A (ja) | 2006-09-28 |
| JP2006522062A5 true JP2006522062A5 (cg-RX-API-DMAC7.html) | 2007-05-17 |
Family
ID=9956223
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006504970A Pending JP2006522062A (ja) | 2003-04-04 | 2004-04-02 | 神経学的障害の処置のための抗癲癇剤を含む組み合わせ |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20060194766A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1620103A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2006522062A (cg-RX-API-DMAC7.html) |
| CN (1) | CN100546581C (cg-RX-API-DMAC7.html) |
| AU (1) | AU2004226825B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0409170A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2521274A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB0307860D0 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA05010707A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004087161A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060252745A1 (en) | 2005-05-06 | 2006-11-09 | Almeida Jose L D | Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use |
| GB0700773D0 (en) | 2007-01-15 | 2007-02-21 | Portela & Ca Sa | Drug therapies |
| US20100168174A1 (en) * | 2007-07-13 | 2010-07-01 | Eisai R&D Management Co., Ltd. | Combination of AMPA Receptor Antagonists and Acetylcholinesterase Inhibitors for the Treatment of Neuropathic Pain |
| WO2009015244A1 (en) * | 2007-07-23 | 2009-01-29 | Synosia Therapeutics | Rufinamide for the treatment of post-traumatic stress disorder |
| ES2742728T3 (es) | 2009-07-22 | 2020-02-17 | PureTech Health LLC | Composiciones para el tratamiento de trastornos mejorados por la activación del receptor muscarínico |
| US10265311B2 (en) | 2009-07-22 | 2019-04-23 | PureTech Health LLC | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
| PT3856182T (pt) | 2018-09-28 | 2026-03-10 | Karuna Therapeutics Inc | Composições e métodos para o tratamento de perturbações melhoradas pela ativação dos recetores muscarínicos |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB864536A (en) * | 1957-11-06 | 1961-04-06 | Sapos S A Lab | ª‡-ethyl-phenylacetylurea |
| GB1028234A (en) * | 1964-01-06 | 1966-05-04 | Ici Ltd | New pharmaceutical compositions comprising 5-aminodibenzocycloheptene derivatives |
| WO1989005642A1 (en) * | 1987-12-22 | 1989-06-29 | Ferkany John W | Dextrorphan potentiator for anticonvulsant composition and method |
| US5095033A (en) * | 1991-03-01 | 1992-03-10 | Laboratoires Biocodex | Method for treating epilepsy |
| IT1261808B (it) * | 1993-07-06 | 1996-06-03 | Impiego di l-carnitina o acido l-carnitine e valproato nel trattamentodei disosrdini convulsivi | |
| DE69724144D1 (de) * | 1996-10-19 | 2003-09-18 | Univ Wales Bangor | Verfahren zur herstellung von chemisch reaktiver stärke |
| CZ141399A3 (cs) * | 1996-10-24 | 1999-07-14 | Novartis Ag | Substituované aminoalkanfosfonové kyseliny, způsob jejich přípravy a farmaceutické prostředky, které je obsahují |
| US6306909B1 (en) * | 1997-03-12 | 2001-10-23 | Queen's University At Kingston | Anti-epileptogenic agents |
| CN1265889A (zh) * | 1999-03-06 | 2000-09-13 | 王学勇 | 一种治疗癫痫病的药物 |
| CA2392879C (en) * | 1999-12-01 | 2005-03-29 | Ucb, S.A. | A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders |
| US6191117B1 (en) * | 2000-07-10 | 2001-02-20 | Walter E. Kozachuk | Methods of producing weight loss and treatment of obesity |
| IL161700A0 (en) * | 2001-11-12 | 2004-09-27 | Novartis Ag | Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain |
-
2003
- 2003-04-04 GB GBGB0307860.7A patent/GB0307860D0/en not_active Ceased
-
2004
- 2004-04-02 AU AU2004226825A patent/AU2004226825B2/en not_active Ceased
- 2004-04-02 MX MXPA05010707A patent/MXPA05010707A/es not_active Application Discontinuation
- 2004-04-02 US US10/550,381 patent/US20060194766A1/en not_active Abandoned
- 2004-04-02 CN CNB2004800092188A patent/CN100546581C/zh not_active Expired - Fee Related
- 2004-04-02 JP JP2006504970A patent/JP2006522062A/ja active Pending
- 2004-04-02 WO PCT/EP2004/003518 patent/WO2004087161A1/en not_active Ceased
- 2004-04-02 EP EP04725366A patent/EP1620103A1/en not_active Withdrawn
- 2004-04-02 BR BRPI0409170-1A patent/BRPI0409170A/pt not_active IP Right Cessation
- 2004-04-02 CA CA002521274A patent/CA2521274A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI762505B (zh) | 細胞代謝過程之抑制劑 | |
| AU2011227398C1 (en) | Modulators of Hec1 activity and methods therefor | |
| JP2022536728A5 (cg-RX-API-DMAC7.html) | ||
| TWI500616B (zh) | 新穎之雙環吡啶酮 | |
| CN111801339B (zh) | 5-氟尿嘧啶化合物 | |
| JP2008500390A5 (cg-RX-API-DMAC7.html) | ||
| AR072688A1 (es) | Nucleosidos y nucleotidos biciclicos como agentes terapeuticos | |
| JP2003513015A5 (cg-RX-API-DMAC7.html) | ||
| EP4218935A1 (en) | Lxrbeta agonist for the treatment of cancer | |
| JP2019514950A5 (cg-RX-API-DMAC7.html) | ||
| JP2005504080A5 (cg-RX-API-DMAC7.html) | ||
| WO2008005956A3 (en) | Pyrrolotriazine kinase inhibitors | |
| JP2019014758A (ja) | デオキシウリジントリホスファターゼ阻害剤 | |
| RU2006107785A (ru) | 2, 4-пиримидиндиамины, применяемые в лечении неопластических болезней, воспалительных и иммунных расстройств | |
| RU96111418A (ru) | ПРОИЗВОДНЫЕ ПИРИМИДИНДИОНА, ПИРИМИДИНТРИОНА, ТРИАЗИНДИОНА, ТЕТРАГИДРОХИНАЗОЛИНДИОНА В КАЧЕСТВЕ АНТАГОНИСТОВ α1 АДРЕНЕРГИЧЕСКИХ РЕЦЕПТОРОВ | |
| JP2004525149A5 (cg-RX-API-DMAC7.html) | ||
| NZ594332A (en) | Compounds for the prevention and treatment of cardiovascular disease | |
| JP2017528494A (ja) | sGC刺激剤 | |
| JP2004527560A5 (cg-RX-API-DMAC7.html) | ||
| AU2017207291A1 (en) | Methods for the treatment of myeloid derived suppressor cells related disorders | |
| JP2016094432A (ja) | キナーゼインヒビター、そのプロドラッグ型および治療におけるそれらの使用 | |
| JP7590351B2 (ja) | Prmt5阻害剤を使用した癌の治療法 | |
| JP2024504632A (ja) | 非アルコール性脂肪肝疾患および関連する疾患または障害を処置または改善するための化合物、組成物および方法 | |
| MA28583B1 (fr) | Dérivés de pyrimidine pour le traitement d'une croissance cellulaire anormale | |
| CA2460135C (en) | Use of pyridazinone compounds as phosphodiesterase iv inhibitors for treating cancer and other diseases |